Cargando…
Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity
Carbonic anhydrase (CA) IX has emerged as a promising target for cancer therapy. It is highly upregulated in hypoxic regions and mediates pH regulation critical for tumor cell survival as well as extracellular acidification of the tumor microenvironment, which promotes tumor aggressiveness via vario...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844713/ https://www.ncbi.nlm.nih.gov/pubmed/28631600 http://dx.doi.org/10.3727/096504017X14965111926391 |
_version_ | 1783644405632073728 |
---|---|
author | Riemann, Anne Güttler, Antje Haupt, Verena Wichmann, Henri Reime, Sarah Bache, Matthias Vordermark, Dirk Thews, Oliver |
author_facet | Riemann, Anne Güttler, Antje Haupt, Verena Wichmann, Henri Reime, Sarah Bache, Matthias Vordermark, Dirk Thews, Oliver |
author_sort | Riemann, Anne |
collection | PubMed |
description | Carbonic anhydrase (CA) IX has emerged as a promising target for cancer therapy. It is highly upregulated in hypoxic regions and mediates pH regulation critical for tumor cell survival as well as extracellular acidification of the tumor microenvironment, which promotes tumor aggressiveness via various mechanisms, such as augmenting metastatic potential. Therefore, the aim of this study was to analyze the complex interdependency between CA IX and the tumor microenvironment in prostate tumor cells with regard to potential therapeutic implications. CA IX was upregulated by hypoxia as well as acidosis in prostate cancer cells. This induction did not modulate intracellular pH but led to extracellular acidification. Pharmacological inhibition of CA IX activity by U104 (SLC-0111) resulted in a reduction in tumor cell growth and an increase in apoptotic cell death. Intracellular pH was reduced under normoxic and even more so under hypoxic conditions when CA IX level was high. However, although intracellular pH regulation was disturbed, targeting CA IX in combination with daunorubicin or cisplatin did not intensify apoptotic tumor cell death. Hence, targeting CA IX in prostate cancer cells can lead to intracellular pH dysregulation and, consequently, can reduce cellular growth and elevate apoptotic cell death. Attenuation of extracellular acidification by blocking CA IX might additionally impede tumor progression and metastasis. However, no beneficial effect was seen when targeting CA IX in combination with chemotherapeutic drugs. |
format | Online Article Text |
id | pubmed-7844713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Cognizant Communication Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-78447132021-02-16 Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity Riemann, Anne Güttler, Antje Haupt, Verena Wichmann, Henri Reime, Sarah Bache, Matthias Vordermark, Dirk Thews, Oliver Oncol Res Article Carbonic anhydrase (CA) IX has emerged as a promising target for cancer therapy. It is highly upregulated in hypoxic regions and mediates pH regulation critical for tumor cell survival as well as extracellular acidification of the tumor microenvironment, which promotes tumor aggressiveness via various mechanisms, such as augmenting metastatic potential. Therefore, the aim of this study was to analyze the complex interdependency between CA IX and the tumor microenvironment in prostate tumor cells with regard to potential therapeutic implications. CA IX was upregulated by hypoxia as well as acidosis in prostate cancer cells. This induction did not modulate intracellular pH but led to extracellular acidification. Pharmacological inhibition of CA IX activity by U104 (SLC-0111) resulted in a reduction in tumor cell growth and an increase in apoptotic cell death. Intracellular pH was reduced under normoxic and even more so under hypoxic conditions when CA IX level was high. However, although intracellular pH regulation was disturbed, targeting CA IX in combination with daunorubicin or cisplatin did not intensify apoptotic tumor cell death. Hence, targeting CA IX in prostate cancer cells can lead to intracellular pH dysregulation and, consequently, can reduce cellular growth and elevate apoptotic cell death. Attenuation of extracellular acidification by blocking CA IX might additionally impede tumor progression and metastasis. However, no beneficial effect was seen when targeting CA IX in combination with chemotherapeutic drugs. Cognizant Communication Corporation 2018-03-05 /pmc/articles/PMC7844713/ /pubmed/28631600 http://dx.doi.org/10.3727/096504017X14965111926391 Text en Copyright © 2018 Cognizant, LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is licensed under a Creative Commons Attribution-NonCommercial NoDerivatives 4.0 International License. |
spellingShingle | Article Riemann, Anne Güttler, Antje Haupt, Verena Wichmann, Henri Reime, Sarah Bache, Matthias Vordermark, Dirk Thews, Oliver Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity |
title | Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity |
title_full | Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity |
title_fullStr | Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity |
title_full_unstemmed | Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity |
title_short | Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity |
title_sort | inhibition of carbonic anhydrase ix by ureidosulfonamide inhibitor u104 reduces prostate cancer cell growth, but does not modulate daunorubicin or cisplatin cytotoxicity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844713/ https://www.ncbi.nlm.nih.gov/pubmed/28631600 http://dx.doi.org/10.3727/096504017X14965111926391 |
work_keys_str_mv | AT riemannanne inhibitionofcarbonicanhydraseixbyureidosulfonamideinhibitoru104reducesprostatecancercellgrowthbutdoesnotmodulatedaunorubicinorcisplatincytotoxicity AT guttlerantje inhibitionofcarbonicanhydraseixbyureidosulfonamideinhibitoru104reducesprostatecancercellgrowthbutdoesnotmodulatedaunorubicinorcisplatincytotoxicity AT hauptverena inhibitionofcarbonicanhydraseixbyureidosulfonamideinhibitoru104reducesprostatecancercellgrowthbutdoesnotmodulatedaunorubicinorcisplatincytotoxicity AT wichmannhenri inhibitionofcarbonicanhydraseixbyureidosulfonamideinhibitoru104reducesprostatecancercellgrowthbutdoesnotmodulatedaunorubicinorcisplatincytotoxicity AT reimesarah inhibitionofcarbonicanhydraseixbyureidosulfonamideinhibitoru104reducesprostatecancercellgrowthbutdoesnotmodulatedaunorubicinorcisplatincytotoxicity AT bachematthias inhibitionofcarbonicanhydraseixbyureidosulfonamideinhibitoru104reducesprostatecancercellgrowthbutdoesnotmodulatedaunorubicinorcisplatincytotoxicity AT vordermarkdirk inhibitionofcarbonicanhydraseixbyureidosulfonamideinhibitoru104reducesprostatecancercellgrowthbutdoesnotmodulatedaunorubicinorcisplatincytotoxicity AT thewsoliver inhibitionofcarbonicanhydraseixbyureidosulfonamideinhibitoru104reducesprostatecancercellgrowthbutdoesnotmodulatedaunorubicinorcisplatincytotoxicity |